148 related articles for article (PubMed ID: 34274020)
1. Characteristics of rifampicin-resistant tuberculosis detection in China, 2015-2019.
Su W; Ruan YZ; Li T; Du X; Jiang JW; Li RZ
Infect Dis Poverty; 2021 Jul; 10(1):99. PubMed ID: 34274020
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
3. Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016-2020.
Yang Y; Liu L; Yang X; Li L; Lu K; Chen J; Xu Z; Xu L
PLoS One; 2023; 18(11):e0280578. PubMed ID: 37971975
[TBL] [Abstract][Full Text] [Related]
4. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
[TBL] [Abstract][Full Text] [Related]
5. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
[TBL] [Abstract][Full Text] [Related]
6. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
[TBL] [Abstract][Full Text] [Related]
7. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
[TBL] [Abstract][Full Text] [Related]
8. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Chiang TY; Fan SY; Jou R
PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
[TBL] [Abstract][Full Text] [Related]
10. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Wasihun AG; Dejene TA; Hailu GG
PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
[TBL] [Abstract][Full Text] [Related]
11. Impact of multiple policy interventions on the screening and diagnosis of drug-resistant tuberculosis patients: a cascade analysis on six prefectures in China.
Ding XY; Mao WH; Lu W; Yu H; Liu Q; Lu P; Jiang H; Zhang X; Lu F; Xu J; Zhong CQ; Hu JL; Jiang WX; Guo L; Tang SL; Zhu LM
Infect Dis Poverty; 2021 Jan; 10(1):8. PubMed ID: 33468247
[TBL] [Abstract][Full Text] [Related]
12. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
[TBL] [Abstract][Full Text] [Related]
13. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
14. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017.
Wu B; Yu Y; Du C; Liu Y; Hu D
PLoS One; 2019; 14(12):e0216018. PubMed ID: 31821321
[TBL] [Abstract][Full Text] [Related]
16. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
[TBL] [Abstract][Full Text] [Related]
17. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.
Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E
S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
20. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
